Comparison Between Rectal & Sublingual Misoprostol Before Caesarian Section To Reduce Intra & Post-Operative Blood Loss
Status:
Completed
Trial end date:
2014-02-01
Target enrollment:
Participant gender:
Summary
The aim of the work is to evaluate & compare the effectiveness of rectally administered PGE1
synthetic analogue (misoprostol) 400 microgram versus sublingually administered misoprostol
before caesarean section to decrease blood loss during and after the operation.